NanoViricides Inc (NNVC)
Official siteHEALTHCARE • BIOTECHNOLOGY • AMEX
Market Cap: $31.41M
Last updated: Nov 17, 2026 at 11:05 AM ET
NanoViricides Inc (NNVC) Stock Forecast
Analysts expect NanoViricides (NNVC) to earn -$0.35 per share in the fiscal year ending Jun 30, 2027. Over the last 30 days, 1 estimate for the fiscal year ending Jun 30, 2027 was revised up and 0 down. For the fiscal year ending Jun 30, 2028, the EPS consensus is -$0.35.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus is unchanged.
- Fiscal year ending Jun 30, 2027
- -$0.35
- EPS consensus
- Fiscal year ending Jun 30, 2028
- -$0.35
- EPS consensus, revenue $76.50M
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Jun 30, 2027 | -$0.35 | -$0.35 to -$0.35 | 1 | N/A | N/A | 1 |
| Jun 30, 2028 | -$0.35 | -$0.35 to -$0.35 | 1 | $76.50M | $76.50M to $76.50M | 1 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.08 | -$0.08 to -$0.08 | 1 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Jun 30, 2027 | 1 | 0 |
| Fiscal year ending Jun 30, 2028 | 0 | 0 |
| Quarter ending Dec 31, 2026 | 0 | 0 |
EPS Trend
The EPS consensus for the fiscal year ending Jun 30, 2027 has held over the last 90 days.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Jun 30, 2027 | -$0.35 | -$0.35 | -$0.35 | -$0.35 | -$0.35 | N/A |
| Fiscal year ending Jun 30, 2028 | -$0.35 | -$0.35 | -$0.35 | -$0.35 | -$0.35 | N/A |
| Quarter ending Dec 31, 2026 | -$0.08 | -$0.08 | -$0.08 | -$0.08 | -$0.08 | N/A |
Frequently Asked Questions About NNVC
What is the NNVC stock forecast?
Consensus analyst estimates put NanoViricides's EPS at -$0.35 for the fiscal year ending Jun 30, 2027.
What EPS do analysts expect from NNVC next year?
For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is -$0.35, with estimates from -$0.35 to -$0.35 from 1 analyst. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is -$0.35, with estimates from -$0.35 to -$0.35 from 1 analyst.
What revenue do analysts expect from NanoViricides next year?
For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $76.50M, with estimates from $76.50M to $76.50M.
How many analysts cover NNVC?
1 analyst estimates EPS for NanoViricides for the fiscal year ending Jun 30, 2027.
NNVC pages: Overview, Earnings, Forecast, Financials, Competitors